AI-Driven Targeted Drug Delivery Service
Creative Biolabs is revolutionizing therapeutic development through our AI-Driven Targeted Drug Delivery Service. We address the critical industry challenge of poor biodistribution and off-target toxicity by ensuring your therapeutic payload reaches its precise site of action. Our intelligent, modular platforms are designed to overcome complex biological barriers, protect payload integrity, and unlock the true potential of your research. Creative Biolabs provides the expert partnership and validated tools to translate your most complex therapeutic concepts into realities.
Contact Our Delivery Experts Today
Overview
What is AI-Driven Targeted Delivery System Design?
AI-driven targeted delivery system design is a sophisticated, multi-stage process that leverages machine learning to build vectors in silico. It begins by:
⭐ 1. Data Input & Target Definition: The process begins with your parameters: the payload (e.g., mRNA, siRNA, small molecule), the biological target (e.g., cell type, receptor), and the desired outcome (e.g., high uptake, endosomal escape).
⭐ 2. Feature Extraction & Model Training: Our AI models are trained on comprehensive in-house and literature data, correlating molecular structures (e.g., lipid chemistry, peptide sequences) with functional outcomes (e.g., BBB penetration, tumor accumulation, immune response).
⭐ 3. In Silico Simulation & Ranking: The AI platform computationally "builds" thousands of potential vehicle-payload combinations from our modular libraries. It then simulates their behavior, predicts their performance (e.g., stability, toxicity, targeting efficiency), and ranks the top candidates.
⭐ 4. Iterative Design & Validation: We synthesize and test the top-ranked candidates. This experimental data is fed back into our models, creating an iterative-learning loop that continuously refines and improves the predictive accuracy for your specific project.
Fig. 1 AI-driven drug delivery system design.1
Traditional delivery formulation has long been a process of trial-and-error, consuming significant time and resources. Creative Biolabs' AI-driven approach transforms this paradigm. This predictive power allows us to rationally design optimal carriers, de-risk your research, and dramatically accelerate your development timeline from discovery to validation.
The Creative Biolabs Solution: An Intelligent, Modular Framework
Traditional delivery formulation has long been a process of trial-and-error, consuming significant time and resources. Creative Biolabs' AI-driven approach transforms this paradigm. We leverage sophisticated machine learning algorithms and proprietary datasets to create in silico models that predict complex payload-vehicle-target interactions before a single formulation is synthesized. This predictive power allows us to rationally design optimal carriers, de-risk your research, and dramatically accelerate your development timeline from discovery to validation.
Our solution is built on two core pillars:
- AI-Powered Predictive Design: We leverage a sophisticated, proprietary AI platform to model and predict delivery outcomes. Our in silico tools analyze complex interactions between payloads, delivery vehicles, and biological targets to identify optimal formulations before they are synthesized.
- Modular Delivery Toolkit: This predictive power is combined with our extensive, ready-to-use libraries of Modular Delivery Systems (the "vehicles") and Targeted Modules (the "GPS").
This "design-build-validate" approach enables you to de-risk your research, save valuable time, and accelerate your development pipeline.
Our AI-Driven Delivery Platform: From Design to Validation
Creative Biolabs provides an end-to-end solution, guiding your project from computational concept to experimentally validated results. Our service is built on four integrated pillars:
AI-Optimized Feature
AI predicts optimal peptide density and LNP lipid composition for enhanced tumor penetration and endosomal escape.
Example Application
Delivery of siRNA or small molecules to integrin-expressing cancer cells (e.g., glioblastoma).
Workflow
Applications of AI-driven Delivery System Development
Our AI-driven delivery services are engineered to accelerate breakthroughs across numerous therapeutic areas by solving the most complex delivery challenges.
- Vaccine Development: Design optimized LNP carriers for mRNA or pDNA vaccines, enhancing antigen expression, adjuvanticity, and thermal stability for next-generation prophylactic or therapeutic vaccines.
- Oncology: Develop "smart" nanocarriers that selectively target tumor cells (e.g., via overexpressed receptors) or respond to the unique conditions of the tumor microenvironment (TME), such as hypoxia or low pH.
- Gene Therapy & Gene Editing: Enable precise in vivo delivery of nucleic acids (mRNA, plasmid DNA) or gene editing components to the nucleus of target cells for gene correction or replacement.
- Immunology & Immunotherapy: Target specific immune cell subsets (e.g., T-cells, macrophages) to modulate the immune response, enhance CAR-T efficacy, or deliver novel immunotherapeutics.
- Neurology & CNS Disorders: Design vectors capable of overcoming the blood-brain barrier (BBB) to deliver therapeutics for neurodegenerative diseases.
Why Choose Creative Biolabs?
AI-Driven Precision
Our proprietary AI platform de-risks your project, reduces R&D costs, and accelerates timelines by replacing trial-and-error with intelligent, predictive design.
Vast Modular Toolkit
We offer an unparalleled, cross-compatible library of carriers and targeting modules, ensuring we find the right combination for your unique payload and target, not a "one-size-fits-all" solution.
Payload-Agnostic Expertise
Our scientists have deep, cross-functional expertise in delivering everything from small molecules and peptides to complex mRNA and gene editing complexes.
End-to-End Collaborative Partnership
We are more than a CRO. We are your dedicated scientific partners, providing transparent communication and expert consultation from project inception to final data delivery.
Proven, Validated, and Reliable
We provide a final data package that is robust, and reproducible, giving you full confidence to move to the next stage of your research.
Leverage our industry-leading expertise in design and development of drug delivery systems. Creative Biolabs is your dedicated R&D partner, transforming computational insights into functionally validated vectors that de-risk and accelerate your pipeline. Don't let delivery be your bottleneck. Contact our scientific team today to begin your project.
Related Services & Products
Related Services
Chemical Synthesis Services
Related Products
| Product Name | Description | Inquiry |
|---|---|---|
| LNP Screening Array Kit | A high-throughput 96-well plate kit for rapidly screening a library of ionizable lipids and formulations. | |
| Targeted LNP Formulation Kit | A complete kit for formulating LNPs functionalized with our proprietary liver, lung, spleen, or muscle targeting lipid. | |
| RNA-LNP Encapsulation Assay Kit | A fast, reliable dye-based assay kit (e.g., RiboGreen) to accurately quantify RNA encapsulation efficiency in your LNP formulations. | |
| LNP Formulation Kit (Universal) | Our baseline formulation kit, containing a standard set of 4 ionizable lipids, PEG-lipid, cholesterol, and helper lipid. |
FAQs
What therapeutic payloads can you work with?
Our platform is payload-agnostic. We have validated protocols for small molecules (hydrophilic and hydrophobic), proteins, peptides, and a wide range of nucleic acids, including siRNA, mRNA, ASOs, DNA plasmids, and gene editing components (RNP or mRNA).
What does the "AI-driven" part of the service actually do?
Our AI platform uses machine learning to analyze vast datasets on how formulation properties (lipid composition, particle size, charge, targeting ligand) correlate with biological outcomes (stability, cellular uptake, endosomal escape, in vivo biodistribution). This allows us to predict and rank the best formulations for your specific project in silico, saving months of empirical lab work.
Can you target a specific organ or cell type?
Yes. This is our core expertise. We achieve this through our Targeted Modules, such as by adding specific peptides (e.g., cRGD) to target tumors or by optimizing lipid compositions to passively target the liver, lungs, or spleen. We will work with you to define the target and select the best strategy.
What do I need to provide to get started?
To start, we only need your target (e.g., cell type, organ) and information on your payload (e.g., mRNA sequence, protein name, small molecule structure). Our expert team will then schedule a confidential consultation to discuss your goals and build a project plan.
Do you work with academic labs as well as pharmaceutical companies?
Absolutely. We partner with researchers at all levels, from academic labs and biotech startups to large pharmaceutical companies. Our services are designed to be flexible to meet both research and pre-clinical development needs.
Reference
- Shirzad, Maryam, et al. "Artificial Intelligence-Assisted Design of Nanomedicines for Breast Cancer Diagnosis and Therapy: Advances, Challenges, and Future Directions." BioNanoScience 15.3 (2025): 354. https://doi.org/10.1007/s12668-025-01980-w. Distributed under Open Access license CC BY 4.0, without modification.
